Interleukin-1 blockade with RPH-104 in patients with acute ST-elevation myocardial infarction: study design and rationale

BACKGROUND: Myocardial injury of ST-segment elevation myocardial infarction (STEMI) initiates an intense inflammatory response that contributes to further damage and is a predictor of increased risk of death or heart failure (HF). Interleukin-1 (IL-1) is a key mediator of local and systemic inflamma...

Descripción completa

Detalles Bibliográficos
Autores principales: Samsonov, M., Bogin, V., Van Tassell, B. W., Abbate, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074403/
https://www.ncbi.nlm.nih.gov/pubmed/33902621
http://dx.doi.org/10.1186/s12967-021-02828-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8074403/
https://www.ncbi.nlm.nih.gov/pubmed/33902621
http://dx.doi.org/10.1186/s12967-021-02828-z

Ejemplares similares